البحث | سنجن

Shweta Kadam أضاف وظيفة جديدة أخرى
2026-02-13 07:40:43 -

Arthritis Market CAGR: Growth, Share, Value, Insights, and Trends
Introduction The Global Arthritis Market represents a critical segment of the broader healthcare and pharmaceutical industry, driven by the rising burden of musculoskeletal disorders worldwide. Arthritis, characterized by inflammation of one or more joints, encompasses more than 100 different conditions, with osteoarthritis and rheumatoid arthritis being the most prevalent. The...

0 التعليقات 0 المشاركات 2 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Shweta Kadam أضاف وظيفة جديدة أخرى
2026-02-12 09:07:44 -

Arthritis Market Revenue Forecast, Future Scope, Challenges, Growth Drivers
"Future of Executive Summary Arthritis Market: Size and Share Dynamics Data Bridge Market Research analyses that the global arthritis market, which was USD 4.3 billion in 2022, would rocket up to USD 8.63 billion by 2030 and is expected to undergo a CAGR of 9.10% during the forecast period. The Arthritis Market report offers an analytical assessment of the prime challenges faced by the...

0 التعليقات 0 المشاركات 6 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Shweta Kadam أضاف وظيفة جديدة أخرى
2026-01-29 06:35:40 -

Rheumatoid Arthritis Treatment Market: Industry Analysis and Forecast
Introduction Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by inflammation, pain, and progressive joint damage. It affects millions of people worldwide, significantly impairing their quality of life and productivity. The management of RA requires a combination of pharmacological interventions, lifestyle modifications, and patient-centric care. As awareness about early...

0 التعليقات 0 المشاركات 27 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Pratiksha Dhote أضاف وظيفة جديدة Health
2025-12-13 10:41:17 -

The Maturing Segment: Assessing TNF-α Antagonists Product Types, Patent Expiries, and the Market Trend toward Biosimilar Adoption
The Tumor Necrosis Factor-alpha (TNF-α) Antagonists represent the most established and largest segment within the biological product types used for Rheumatoid Arthritis. Having revolutionized treatment decades ago, these injectable therapies have a wealth of clinical data supporting their efficacy and long-term use cases in moderate-to-severe disease. However, this segment is now reaching...

0 التعليقات 0 المشاركات 153 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!